Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report

Background: The landscape of melanoma management changed as randomized trials have launched adjuvant treatment. Materials and Methods: An analysis of data on 248 consecutive melanoma stage III and IV patients given adjuvant therapy in eight centers (February 2019 to January 2021) was conducted. Resu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2023-09, Vol.15 (17), p.4384
Hauptverfasser:	Placzke, Joanna, Rosińska, Magdalena, Sobczuk, Paweł, Ziętek, Marcin, Kempa-Kamińska, Natasza, Cybulska-Stopa, Bożena, Kamińska-Winciorek, Grażyna, Bal, Wiesław, Mackiewicz, Jacek, Galus, Łukasz, Las-Jankowska, Manuela, Jankowski, Michał, Dziura, Robert, Drucis, Kamil, Borkowska, Aneta, Świtaj, Tomasz, Rogala, Paweł, Kozak, Katarzyna, Klimczak, Anna, Jagodzińska-Mucha, Paulina, Szumera-Ciećkiewicz, Anna, Koseła-Paterczyk, Hanna, Rutkowski, Piotr
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant therapy Biopsy Clinical trials Dissection Drug dosages Immunotherapy Lymph nodes Lymphatic system Melanoma Metastases Metastasis Patients PD-1 protein Pembrolizumab Performance evaluation Radiation therapy Surgery Survival Survival analysis Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!